STOCK TITAN

Bio-Key International Inc. - BKYI STOCK NEWS

Welcome to our dedicated news page for Bio-Key International (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key International.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bio-Key International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bio-Key International's position in the market.

Rhea-AI Summary
BIO-key International, Inc. has closed its public offering of 21,430,000 units, each consisting of one share of common stock and one warrant. The units were sold at a price of $0.175 per unit, resulting in gross proceeds of approximately $3.75 million. The warrants are immediately exercisable at $0.175 per share and will expire in five years. Maxim Group LLC acted as the sole placement agent for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
-
Rhea-AI Summary
BIO-key International, Inc. announces the pricing of its public offering of 21,430,000 units at a price of $0.175 per unit. The gross proceeds are expected to be approximately $3.75 million. The offering is expected to close on October 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.27%
Tags
-
Rhea-AI Summary
BIO-key International, Inc. has announced that the Ministry of Defense of Montenegro has deployed AuthControl Sentry for secure IAM for all government employees. The project aims to require MFA for login and simplify the user experience through SSO integration with web and legacy applications. The deployment was managed by REAL security d.o.o, a trusted partner of BIO-key EMEA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.27%
Tags
none
Rhea-AI Summary
BIO-key International has announced that ALPI Portugal has deployed AuthControl Sentry for enhanced data access security. The solution will utilize Multi-factor Authentication (MFA) access and Single Sign-on (SSO) to secure data access by all internal users, including employees and third-party drivers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.41%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. announced its Q3'23 results, with revenue rising over 30% to $1.8M, gross profit improving more than 40% to $1.4M, and operating loss improving to approximately ($750,000). Q3'23 net loss per share reduced approximately 72% to ($0.08). The company's CEO expressed confidence in continued growth and improved bottom-line performance in 2024. BIO-key also secured a significant commitment from a long-standing international defense ministry customer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.05%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. will sponsor and exhibit at ISC2 Security Congress 2023, showcasing their phoneless, tokenless, and passwordless IAM solutions. BIO-key's unified IAM platform, PortalGuard®, offers Identity-Bound Biometrics (IBB) authentication, which eliminates the use of phones or tokens. This unique solution addresses the need for strong multi-factor authentication (MFA) and provides high levels of usability and security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.05%
Tags
none
Rhea-AI Summary
BIO-key International, Inc. to participate in Virtual Tech Conference Series
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
conferences
-
Rhea-AI Summary
BIO-key accepted into AWS ISV Accelerate Program, enhancing biometric security solutions on AWS
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BIO-key to participate in H.C. Wainwright's Global Investment Conference on Sep 11-12, CEO available for meetings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
conferences
Rhea-AI Summary
BIO-key International, Inc. (Nasdaq: BKYI) reported Q2’23 revenues of $1.9M, almost equal to Q2’22, with a 29% increase in the first six months of FY’23. The company experienced delays in closing larger customer opportunities, including a $0.3M defense ministry order signed in early Q3’23. Despite this, BIO-key's PortalGuard IDaaS traction supported healthcare migrations to Epic Hyperdrive, and they expanded their global distribution partner network. CEO Michael DePasquale expressed confidence in the company's strong foundation for growth and improving bottom-line performance, emphasizing the growing pipeline of customer opportunities and the expanding global partner network.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
Bio-Key International Inc.

Nasdaq:BKYI

BKYI Rankings

BKYI Stock Data

3.31M
622.85k
4.93%
5.47%
1.04%
Software Publishers
Information
Link
US
Wall Township

About BKYI

bio-key international, inc. (otcqb: bkyi), is a trusted provider of enterprise and consumer biometric software and hardware authentication solutions. established in 1993 customers include the fortune 500, government agencies, healthcare organizations, call centers, schools, retailers, and oem partners. in 2016, the company introduced a line of compact fingerprint readers that have been tested and qualified for use with windows hello. these affordable and easy to install / easy to use readers are available through amazon, microsoft, dell.com and other leading retailers. at the consumer electronic show 2017, bio-key launched a series of biometric padlocks. touchlock won top product and was featured on more than 30+ morning television shows. looking into the future bio-key remains committed to developing the biometric of things (bot) a series of biometrically enabled consumer friendly products. all inspired by the power of a touch.